Pool Corporation (POOL) is trading down at $182.35 (-1.24%) on NYSE/NASDAQ, as of the latest quote. It is a S&P 500 constituent in the Consumer Discretionary sector.
Poolbeg Pharma receives FDA feedback on cancer therapy POLB 001
Poolbeg Pharma receives FDA feedback on cancer therapy POLB 001